We have previously shown that the release of cfDNA from dying tissue or activated neutrophils leads to a rapid systemic AIM2-mediated inflammasome activation and subsequent increased levels of circulating IL-1β after stroke. This evidence concerns the gene IL1B and stroke disorder.